The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Neurofibromatosis type 2
Open accessAbstract
Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tumour suppressor gene located on chromosome 22q. It has a frequency of one in 25 000 livebirths and nearly 100% penetrance by 60 years of age. Half of patients inherit a germline mutation from an affected parent and the remainder acquire a de novo mutation for neurofibromatosis type 2. Patients develop nervous system tumours (schwannomas, meningiomas, ependymomas, astrocytomas, and neurofibromas), peripheral neuropathy, ophthalmological lesions (cataracts, epiretinal membranes, and retinal hamartomas), and cutaneous lesions (skin tumours). Optimum treatment is multidisciplinary because of the complexities associated with management of the multiple, progressive, and protean lesions associated with the disorder. We review the molecular pathogenesis, genetics, clinical findings, and management strategies for neurofibromatosis type 2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
Self-citationTrofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
A Clinical Study of Type 2 Neurofibromatosis
(1992) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068699 · Cited by 634
Evans, D. G., Huson, S. M., Donnai, D., Neary, W., Blair, V, Teare, D., Newton, V, Strachan, T., Ramsden, R., & Harris, R. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.12.841 · Cited by 468
Parry, D. M., Eldridge, R., Kaiser‐Kupfer, M. I., Bouzas, E. A., Pikus, A., & Patronas, N. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320520411 · Cited by 421
Self-citationEvans, D. G. R., Moran, A., King, A., Saeed, S., Gurusinghe, N., & Ramsden, R. (2005) · Otology & Neurotology · doi:10.1097/00129492-200501000-00016 · Cited by 418
Germline Mutation of INI1/SMARCB1 in Familial Schwannomatosis
Hulsebos, T. J. M., Plomp, A. S., Wolterman, R. A., Robanus-Maandag, E. C., Baas, F., & Wesseling, P. (2007) · The American Journal of Human Genetics · doi:10.1086/513207 · Cited by 398
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Faryniarz, A. G., Chao, M. V., Huson, S., Korf, B. R., Parry, D. M., Pericak-Vance, M. A., et al. (1987) · Cell · doi:10.1016/0092-8674(87)90534-4 · Cited by 368
Self-citationContact-dependent inhibition of EGFR signaling by Nf2/Merlin
Curto, M., Cole, B. K., Lallemand, D., Liu, C.-H., & McClatchey, A. I. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703010 · Cited by 363
The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling
Shaw, R. J., Paez, J. G., Curto, M., Yaktine, A., Pruitt, W. M., Saotome, I., O'Bryan, J. P., Gupta, V., Ratner, N., Der, C. J., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00009-0 · Cited by 343
The Neuroimaging and Clinical Spectrum of Neurofibromatosis 2
Mautner, V.-F., Lindenau, M., Baser, M. E., Hazim, W., Tatagiba, M., Hasse, W., Samii, M., Wais, R., & Pulst, S.-M. (1996) · Neurosurgery · doi:10.1097/00006123-199605000-00004 · Cited by 301
Evans, D. G. R., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036319 · Cited by 301
Management of the patient and family with neurofibromatosis 2: a consensus conference statement
Evans, D., Baser, M., O'Reilly, B., Rowe, J., Gleeson, M., Saeed, S., King, A., Huson, S., Kerr, R., Thomas, N., et al. (2005) · British Journal of Neurosurgery · doi:10.1080/02688690500081206 · Cited by 261
Common Pathogenetic Mechanism for Three Tumor Types in Bilateral Acoustic Neurofibromatosis
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., et al. (1987) · Science · doi:10.1126/science.3105060 · Cited by 256
Kissil, J. L., Johnson, K. C., Eckman, M. S., & Jacks, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200083200 · Cited by 254
Multichannel auditory brainstem implant: update on performance in 61 patients
Otto, S. R., Brackmann, D. E., Hitselberger, W. E., Shannon, R. V., & Kuchta, J. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.6.1063 · Cited by 253
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types
Bianchi, A. B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A. J. P., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F., Seizinger, B. R., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-185 · Cited by 230
Interdomain binding mediates tumor growth suppression by the NF2 gene product
Sherman, L., Xu, H.-M., Geist, R. T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, P., & Gutmann, D. H. (1997) · Oncogene · doi:10.1038/sj.onc.1201418 · Cited by 230
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D. H., & Giovannini, M. (2002) · Genes & Development · doi:10.1101/gad.226302 · Cited by 224
Evans, D. G., Trueman, L., Wallace, A., Collins, S., & Strachan, T. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.6.450 · Cited by 224
Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac
Morrison, H., Sperka, T., Manent, J., Giovannini, M., Ponta, H., & Herrlich, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1608 · Cited by 223
Evaluation of clinical diagnostic criteria for neurofibromatosis 2
Baser, M. E., Friedman, J. M., Wallace, A. J., Ramsden, R. T., Joe, H., & Evans, D. G. R. (2002) · Neurology · doi:10.1212/01.wnl.0000035638.74084.f4 · Cited by 222
Tumors of the Nervus Acusticus, and the Syndrome of the Cerebellopontile Angle
Cushing, H. W. (2010) · University of Michigan Library Repository · Cited by 218
Spinal cord astrocytoma: pathological and treatment considerations
Minehan, K. J., Shaw, E. G., Scheithauer, B. W., Davis, D. L., & Onofrio, B. M. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.83.4.0590 · Cited by 214
Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.
Dumanski, J. P., Carlbom, E., Collins, V. P., & Nordenskjöld, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9275 · Cited by 214
Mautner, V. F., Tatagiba, M., Lindenau, M., Fünsterer, C., Pulst, S. M., Baser, M. E., Kluwe, L., & Zanella, F. E. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.4.7676998 · Cited by 199
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
Jin, H., Sperka, T., Herrlich, P., & Morrison, H. (2006) · Nature · doi:10.1038/nature04856 · Cited by 193
Paediatric presentation of type 2 neurofibromatosis
Evans, D. G. R., Birch, J. M., & Ramsden, R. T. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.6.496 · Cited by 191
Increasing the specificity of diagnostic criteria for schwannomatosis
Baser, M. E., Friedman, J. M., & Evans, D. G. (2006) · Neurology · doi:10.1212/01.wnl.0000201190.89751.41 · Cited by 158
Schwartz, M. S., Otto, S. R., Shannon, R. V., Hitselberger, W. E., & Brackmann, D. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.068 · Cited by 156
Patronas, N., Courcoutsakis, N. A., Bromley, C. M., Katzman, G. L., MacCollin, M., & Parry, D. M. (2001) · Radiology · doi:10.1148/radiology.218.2.r01fe40434 · Cited by 151
Self-citationCase of Tumours in the Skull, Dura Mater, and Brain.
Wishart, J. H. (1822) · PubMed Central · Cited by 149
Rowe, J. G., Radatz, M. W. R., Walton, L., Soanes, T., Rodgers, J., & Kemeny, A. A. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1288 · Cited by 144
Giovannini, M., Robanus-Maandag, E. C., Niwa‐Kawakita, M., van der Valk, M., Woodruff, J. M., Goutebroze, L., Merel, P., Berns, A. J. M., & Thomas, G. D. (1999) · Genes & Development · doi:10.1101/gad.13.8.978 · Cited by 144
Alfthan, K., Heiska, L., Grönholm, M., Renkema, G. H., & Carpén, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313916200 · Cited by 142
Baser, M. E., Kuramoto, L., Joe, H., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422700 · Cited by 138
Cochlear Implantation in the Neurofibromatosis Type 2 Patient: Long‐Term Follow‐up
Neff, B. A., Wiet, R. M., Lasak, J. M., et al. (2007) · The Laryngoscope · doi:10.1097/mlg.0b013e31804b1ae7 · Cited by 136
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
Sperfeld, A. D., Hein, C., Schröder, J. M., Ludolph, A. C., & Hanemann, C. O. (2002) · Brain · doi:10.1093/brain/awf115 · Cited by 134
Rong, R., Surace, E. I., Haipek, C. A., Gutmann, D. H., & Ye, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207794 · Cited by 134
Sobel, R. A., & Wang, Y. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199303000-00002 · Cited by 131
Intramedullary Spinal Cord Tumors in Neurofibromatosis
Lee, M. W., Rezai, A. R., Freed, D. L., & Epstein, F. J. (1996) · Neurosurgery · doi:10.1097/00006123-199601000-00009 · Cited by 122
Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2
Otsuka, G., Saito, K., Nagatani, T., et al. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.3.0480 · Cited by 91
The diagnosis and management of neurofibromatosis 2 in childhood
MacCollin, M., & Mautner, V. (1998) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(98)80003-x · Cited by 91
Magnetic Resonance Imaging of Intramedullary Spinal Cord Tumors
Lowe, G. M. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006462321234 · Cited by 83
Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2
Wiederhold, T., Lee, M., James, M. F., Neujahr, R., Smith, N., Murthy, A. E., Hartwig, J. H., Gusella, J. F., & Ramesh, V. (2004) · Oncogene · doi:10.1038/sj.onc.1208110 · Cited by 78
Lim, H. H., Lenarz, T., Joseph, G., Battmer, R., Samii, A., Samii, M., Patrick, J. F., & Lenarz, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3123-07.2007 · Cited by 71
Hearing Changes after Diagnosis in Neurofibromatosis Type 2
Masuda, A., Fisher, L. M., Oppenheimer, M. R., Iqbal, Z., & Slattery, W. H. (2004) · Otology & Neurotology · doi:10.1097/00129492-200403000-00012 · Cited by 69
Amiodarone-Induced Gynecomastia
Pearson-Webb, M. A., Kaiser‐Kupfer, M. I., & Eldridge, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152419 · Cited by 65
Lee, J., Kim, H., Ryu, C. H., Kim, J., Choi, B. H., Lim, Y., Huh, P., Kim, Y. H., Lee, K.-H., Jun, T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312083200 · Cited by 64
Self-citationOmeis, I. A., Hillard, V. H., Braun, A., Benzil, D. L., Murali, R., & Harter, D. H. (2006) · Surgical Neurology · doi:10.1016/j.surneu.2005.09.034 · Cited by 60
Distribution of Nonvestibular Cranial Nerve Schwannomas in Neurofibromatosis 2
Fisher, L. M., Doherty, J. K., Lev, M. H., et al. (2007) · Otology & Neurotology · doi:10.1097/mao.0b013e31815a8411 · Cited by 59
Lens opacities in neurofibromatosis 2: further significant correlations.
Bouzas, E. A., Freidlin, V., Parry, D. M., Eldridge, R., & Kaiser‐Kupfer, M. I. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.6.354 · Cited by 56
Self-citationScoles, D. R., Yong, W. H., Qin, Y., Wawrowsky, K., & Pulst, S. M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl021 · Cited by 56
Thomas, P. K., King, R. H. M., Chiang, T. R., Scaravilli, F., Sharma, A. K., & Downie, A. W. (1990) · Muscle & Nerve · doi:10.1002/mus.880130202 · Cited by 45
Ryu, C. H., Kim, S.-W., Lee, K. H., Lee, J., Kim, H., Lee, W. K., Choi, B. H., Lim, Y., Kim, Y. H., Lee, K.-H., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208633 · Cited by 34
Self-citationRole of NF2 Haploinsufficiency in NF2‐associated Polyneuropathy
Hanemann, C. O., Diebold, R., & Kaufmann, D. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00086.x · Cited by 22
A case of neurofibromatosis 2 presenting with a mononeuritis multiplex.
Kilpatrick, T. J., Hjorth, R., & Gonzales, M. F. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.5.391 · Cited by 18
Genotype-phenotype correlations for cataracts in neurofibromatosis 2
Baser, M. E., Kuramoto, L., Joe, H., Friedman, J. M., Wallace, A. J., Ramsden, R. T., & Evans, D. G. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.758 · Cited by 16
Cited by
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Role of Merlin/NF2 inactivation in tumor biology
Petrilli, A. M., & Fernández-Valle, C. (2016) · Oncogene · doi:10.1038/onc.2015.125 · Cited by 458
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Moroishi, T., Park, H. W., Qin, B., Chen, Q., Meng, Z., Plouffe, S. W., Taniguchi, K., Yu, F.-X., Karin, M., Pan, D., et al. (2015) · Genes & Development · doi:10.1101/gad.262816.115 · Cited by 369
Menendez, D., Nguyen, T.-A., Freudenberg, J. M., Mathew, V. J., Anderson, C. W., Jothi, R., & Resnick, M. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt504 · Cited by 154
Metadata
- Authors
- Asthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 373
- Issue
- 9679
- Pages
- 1974-1986
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2023011946
- Cited by
- 665
- References
- 61
- FWCI
- 18.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.